Innovative Health Initiative grant of EUR 24 million to improve cancer treatments

The Innovative Health Initiative has awarded a EUR 24 million grant to the IMAGIO consortium of clinical partners coordinated by Philips, with additional resources and funding by industry partners. The consortium will carry out research into improving clinical outcomes through less invasive treatments for lung cancer, liver cancer and soft tissue sarcomas.

Dennis Schaart, head of the section Medical Physics & Technology at the Radiation Science & Technology department of Delft University of Technology (TU Delft):  “Within IMAGIO, TU Delft together with UMC Utrecht is developing a new type of radiation detector that can be used for simultaneous X-ray and nuclear imaging. Such detectors are needed for the development of a hybrid C-arc for image guidance during radioembolization, a successful new cancer treatment using radionuclides. It is a technically challenging project that can make the treatment even more accurate. At least as important, however, is that these detectors enable a much more efficient workflow. When we succeed, this technology will help save costs, relieve the pressure on cancer care and make treatment more patient-friendly.”

The Innovative Health Initiative (IHI) announced June 14, 2023 that the IMAGIO consortium of clinical partners has been awarded a EUR 24 million grant, complemented with additional resources and funding by industry partners, to carry out research into less invasive cancer treatments. Consisting of approximately 30 partners including hospitals, academic institutes, smaller and larger companies, as well as healthcare professional and patient organizations. The consortium will use the funding to develop interventional oncology innovations focused on lung cancer, liver cancer and soft tissue sarcomas. 

The full press release: https://imagioproject.eu/